Using mild intermittent hypoxia to prevent autonomic dysfunction in spinal cord injury patients
Official title: Mild Intermittent Hypoxia: A Prophylactic for Autonomic Dysfunction in Individuals With Spinal Cord Injuries
Run by VA Office of Research and Development · NCT05351827 · Data updated 2026-11-12
This study is testing if mild intermittent hypoxia can help people with spinal cord injuries improve their blood pressure control and overall health by preventing autonomic dysfunction.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 60 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | VA Office of Research and Development Federal |
| Locations | 1 site (Detroit, Michigan) |
| Status | Recruiting |
| Started | October 1, 2022 |
| Main results expected | October 29, 2027 |
| Study ends | October 29, 2027 |
| Registry record updated | August 14, 2026 |
| Trial ID | NCT05351827 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18-60 with motor incomplete spinal cord injuries at or above the 12th thoracic vertebrae who exhibit signs of autonomic dysfunction.
✕Probably not a fit
Patients with complete spinal cord injuries or those with other significant health issues such as insulin-dependent diabetes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of mild intermittent hypoxia (MIH) as a preventive measure for autonomic dysfunction in individuals with spinal cord injuries (SCI). Patients with SCI above the 6th thoracic vertebrae often experience severe autonomic dysfunction, leading to conditions like autonomic dysreflexia and orthostatic hypotension. The study aims to determine if exposure to MIH can restore blood pressure control and improve overall health outcomes for these patients. Participants will be monitored for changes in autonomic function and related health metrics during the intervention.
Why it matters
Potential benefit: If successful, this approach could significantly improve blood pressure control and reduce cardiovascular risks for patients with spinal cord injuries.
How similar studies have gone: While the use of mild intermittent hypoxia is a novel approach in this context, similar interventions have shown promise in improving health outcomes in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Motor incomplete spinal cord injury at or above the 12th thoracic vertebrae * Signs or symptoms of autonomic dysfunction (this will be determined by the Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) and ISAFSCI questions. The ADFSCI requires a score of 1 on questions 16 and 22, and the International Standards to document Autonomic Function following SCI (ISAFSCI) requires a score of 1 on any parameter) * Chronic injuries (\>1 year post injury) Exclusion Criteria: * Pregnant * Smoker * Drug addiction * Complete spinal cord injury * Spinal cord injury below the 6th thoracic vertebrae * Insulin dependent diabetes * Shift workers (i.e., disrupted circadian rhythm) * Active skin breakdown or pressure sores
Where it's running
-
John D. Dingell VA Medical Center, Detroit, MI
Detroit, Michigan, United States Recruiting
Study contacts
- Principal investigator: Gino Panza, PhD — John D. Dingell VA Medical Center, Detroit, MI
- Study coordinator: Gino Panza, PhD
- Email: Gino.Panza@va.gov
- Phone: (313) 576-1000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Autonomic dysreflexia and bladder filling speed in people with spinal cord injury.
Researchers will test whether different bladder filling speeds during urodynamic testing change how often or how severely autonomic dysreflexia happens in people with chronic spinal cord injury.
-
Transcutaneous spinal cord stimulation with 4-aminopyridine and intensive rehab for chronic spinal cord injury
This pilot study tests whether combining noninvasive spinal stimulation, dalfampridine, and rigorous rehab is safe and feasible for adults with chronic spinal cord injury and whether it can help improve movement and walking.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Robot-assisted training for arm and leg movement after stroke or injury
This study tests whether adding ZEPU-AI robotic training to usual therapy is safe and helps adults with arm or leg movement problems from stroke, spinal cord injury, brain injury, or orthopedic conditions.
-
ZEPU-AI3 Lower Limb Feedback Training and Evaluation Robot in Rehab
This pilot trial tests whether adding the ZEPU-AI3 robotic leg training with real-time feedback to standard rehab helps adults with lower limb motor problems from stroke, spinal cord injury, or similar conditions.
-
Combined magnetic stimulation and ultrasound for detrusor overactivity in spinal cord injury
This study tests whether using high-frequency sacral nerve stimulation together with bladder-directed ultrasound can reduce involuntary bladder contractions and improve bladder function in people with spinal cord injury.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.